iCeutica works with pharmaceutical partners to create new branded medicines by combining our proprietary SoluMatrix™ Fine Particle Technology with our partners’ product experience and commercial insights.
The resulting products provide meaningful clinical benefits for patients and have clearly defined pathways to regulatory and commercial success. There are numerous FDA approved and late-stage products in development that utilize our SoluMatrix technology.
iCeutica is also pursuing a multitude of proprietary product and collaboration opportunities in commercially and clinically important areas. In addition to our work with pharmaceutical partners we are advancing our own pipeline of product candidates that address broad indications, including pain and inflammation, oncology, and respiratory diseases.